Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
- DOI
- 10.7554/elife.41305
- Published
- 2018 Nov 15
- Container
- eLife
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7554/elife.41305,
title = {Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.},
author = {Brien GL and Remillard D and Shi J and Hemming ML and Chabon J and Wynne K and Dillon ET and Cagney G and Van Mierlo G and Baltissen MP and Vermeulen M and Qi J and Fröhling S and Gray NS and Bradner JE and Vakoc CR and Armstrong SA},
year = {2018},
journal = {eLife},
doi = {10.7554/elife.41305},
url = {https://doi.org/10.7554/elife.41305}
}RIS
TY - JOUR TI - Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma. AU - Brien GL AU - Remillard D AU - Shi J AU - Hemming ML AU - Chabon J AU - Wynne K AU - Dillon ET AU - Cagney G AU - Van Mierlo G AU - Baltissen MP AU - Vermeulen M AU - Qi J AU - Fröhling S AU - Gray NS AU - Bradner JE AU - Vakoc CR AU - Armstrong SA PY - 2018 JO - eLife DO - 10.7554/elife.41305 UR - https://doi.org/10.7554/elife.41305 ER -
APA
GL, B., D, R., J, S., ML, H., J, C., K, W., ET, D., G, C., G, V. M., MP, B., M, V., J, Q., S, F., NS, G., JE, B., CR, V., & SA, A. (2018). Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.. eLife. https://doi.org/10.7554/elife.41305
Source records
- pubmed · retrieved 2026-09-24T18:52:19.720Z